A one-year trial of lamivudine for power hepatitis B. Asia Hepatitis Lamivudine Research Group. METHODS In preliminary trials, lamivudine, an oral nucleoside analogue, has proven promise for the remedy of power hepatitis B. We carried out a one-year, double-blind trial of lamivudine in 358 Chinese language sufferers with power hepatitis B….